Crain's Detroit7d
Once-growing diabetes startup backed by Blue Cross files for bankruptcy
Bashan declined to reveal how much the company owed creditors, but in its bankruptcy filing in U.S. Bankruptcy Court in ...
$35 insulin: Who in the US benefits?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
Forbes24d
CVS Shares Fall 10% After Replacing CEO—Lowering Earnings Projections
CVS Health is one of three pharmacy benefit managers targeted in a lawsuit from the Federal Trade Commission, which has accused the companies of driving up the price of insulin. The three firms ...
CNN24d
CVS names new CEO in the wake of layoffs and poor stock performance
In September, the Federal Trade Commission took aim at big pharmacy benefits managers, including CVS subsidiary Caremark, accusing them of inflating insulin prices. “We are not surprised by the ...
USA Today18d
As insulin shortages persist, what diabetes patients can do
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...
Politico26d
Localities hit PBMs, pharma on insulin
INSULIN LITIGATION DEEP-DIVE — As Congress ... Jersey district court against the three major pharmacy middlemen — CVS Caremark, Express Scripts and OptumRx — and three insulin manufacturers.